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We read with great interest the recent review by Limongi
et al. on sepsis biomarkers [1]. Recently, the combined use of
two biomarkers, procalcitonin (PCT) and mid-regional pro-
adrenomedullin (MR-proADM) has been reported in sepsis
diagnosis and prognosis. PCT is a polypeptide produced as
a precursor of calcitonin by thyroid C cells normally not
detectable in healthy individuals, but increased during bacterial
infections. For this characteristic, PCT demonstrated high
reliability in the early diagnosis of sepsis compared to other
biomarkers, such as C-reactive protein [2].
Adrenomedullin is a vasodilatory peptide expressed by many
different tissues. Increased levels of adrenomedullin and its
prohormone MR-proADM are found in many diseases, such as
heart failure, cancer and infections and are associated with dis-
ease severity [3]. This biomarker is showed to play a role during
host defense against bacterial infections, in fact it can induce
hyperdynamic circulation during the early stages of sepsis and
the progression to septic shock [4,5]. Recently, MR-proADM
has been proposed as a useful biomarker to predict the
severity and outcome of sepsis [6].
In the last years, many articles have been published on the
role of PCT and MR-proADM in the diagnosis and prognosis
of bacterial infections in different settings. Angeletti et al.
showed that MR-proADM differentiates sepsis from nonin-
fectious systemic inﬂammatory response syndrome with high
speciﬁcity and that the simultaneous measurement of MR-
proADM and PCT in septic patients increases the post-test
diagnostic probability compared to the independent determi-
nation of individual markers [7]. Furthermore, in a recent study,
PCT and MR-proADM were described as promising markers inthe management of febrile patients with hematological malig-
nancies [8].
Recently, the measurement of PCT, MR-proADM, compared
to a panel of 12 cytokines, potentially involved in bacterial
systemic infections response, was reported. The receiver oper-
ating characteristic curve analysis suggested that PCT, MR-
proADM, tumor necrosis factor (TNF)-a were useful markers
for sepsis diagnosis. The best post-test probability was found
with the combination of PCT with MR-proADM or PCT with
TNF-a compared to the single marker determination. Authors,
interestingly proposed a composite score derived from PCT,
MR-proADM, and TNF-a values showing high reliability in the
early diagnosis of sepsis [9].
A score derived from the combination of PCT and MR-
proADM has been recently proposed as a useful clinical tool
to provide rapid diagnosis as well as suggest prognosis of bac-
terial infections. The combined score, calculated on the basis of
deﬁned score assigned for each PCT and MR-proADM value,
can predict bacterial infections and differentiate localized in-
fections from systemic infections, as suggested by receiver
operating characteristic curve analysis. On the basis of the score
values, localized infections could be differentiated from sys-
temic infections and the severity of the infectious disease can be
predicted [10].
For this reason, the use of the combined score was further
recommended with serial measurement in the days following the
diagnosis of bacterial infections. This evaluation could evidence
the worsening of the clinical condition or the absence of
response to the antimicrobial therapy.
The importance of the use of this multi-marker approach in
the diagnosis and prognosis of sepsis is more evident since the
publication of the new deﬁnition of sepsis that has been updatedle under the CC BY-NC-ND license (http://
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represented by experts gathered by the Society of Critical Care
Medicine and the European Society of Intensive Care Medicine
produced new recommendations and established that “Sepsis
should be deﬁned as life-threatening organ dysfunction caused
by a dysregulated host response to infection. For clinical oper-
ationalization, organ dysfunction can be represented by an in-
crease in the sequential (sepsis-related) organ failure assessment
score of 2 points or more, which is associated with an in-hospital
mortality greater than 10%. Septic shock should be deﬁned as a
subset of sepsis in which particularly profound circulatory,
cellular, and metabolic abnormalities are associated with a
greater risk of mortality than with sepsis alone. Patients with
septic shock can be clinically identiﬁed by a vasopressor
requirement to maintain a mean arterial pressure of 65 mmHg or
greater and serum lactate level greater than 2 mmol/L (> 18 mg/
dL) in the absence of hypovolemia. This combination is asso-
ciated with hospital mortality rates greater than 40%” [11–13].
In conclusion, upon this new deﬁnition of sepsis, the use of a
multi-marker approach based on PCT and MR-proADM com-
bination represents a valid tool to identify and deﬁne a systemic
bacterial infection that is evolving and producing an organ
dysfunction.Conﬂict of interest statement
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